Response of host inflammasomes to viral infection

Trends in Microbiology

Volumn 23, Issue 1, 2015, Pages 55-63

  Chen, I Yin ^a   Ichinohe, Takeshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Caspase; IL 1 ; Inflammasome; NLRP3; Pattern recognition receptors; Viroporin

Indexed keywords

CASPASE; CRYOPYRIN; DOUBLE STRANDED RNA; INFLAMMASOME; INTERFERON INDUCIBLE IFI200 FAMILY MEMBER ABSENT IN MELANOMA PROTEIN 2; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; AIM2 PROTEIN, HUMAN; CARRIER PROTEIN; CYTOSKELETON PROTEIN; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MARENOSTRIN; MITOCHONDRIAL PROTEIN; NLRP3 PROTEIN, HUMAN; NLRX1 PROTEIN, HUMAN; VIRUS PROTEIN;

CELL DAMAGE; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME ACTIVATION; HOST CELL; HUMAN; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE BINDING SITE; OLIGOMERIZATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; VIRUS CELL INTERACTION; VIRUS INFECTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PATHOLOGY; RNA VIRUS; SIGNAL TRANSDUCTION;

ENCEPHALOMYOCARDITIS VIRUS; INFLUENZA A VIRUS;

CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DEAD-BOX RNA HELICASES; DNA-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMASOMES; MITOCHONDRIAL PROTEINS; NF-KAPPA B; RNA VIRUSES; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS DISEASES;

EID: 84920547918     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.09.007     Document Type: Review

References (89)

1. Medzhitov R., Janeway C.A. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 1997, 9:4-9.
2. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296:298-300.
3. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
4. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007, 19:24-32.
5. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
6. Huysamen C., Brown G.D. The fungal pattern recognition receptor, dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol. Lett. 2009, 290:121-128.
7. Ting J.P., et al. The NLR gene family: a standard nomenclature. Immunity 2008, 28:285-287.
8. Roberts T.L., et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009, 323:1057-1060.
9. Kato H., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28.
10. Garlanda C., et al. The interleukin-1 family: back to the future. Immunity 2013, 39:1003-1018.
11. Martinon F., Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007, 14:10-22.
12. Martinon F., et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 2002, 10:417-426.
13. Kufer T.A., et al. NACHT-LRR proteins (NLRs) in bacterial infection and immunity. Trends Microbiol. 2005, 13:381-388.
14. Petrilli V., et al. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 2007, 19:615-622.
15. Agostini L., et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20:319-325.
16. McDermott M.F. Genetic clues to understanding periodic fevers, and possible therapies. Trends Mol. Med. 2002, 8:550-554.
17. Hise A.G., et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009, 5:487-497.
18. Mariathasan S., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
19. Duncan J.A., et al. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J. Immunol. 2009, 182:6460-6469.
20. Kanneganti T.D., et al. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 2006, 281:36560-36568.
21. Yamasaki K., et al. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1β) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 2009, 284:12762-12771.
22. Li H., et al. Cutting edge: necrosis activates the NLRP3 inflammasome. J. Immunol. 2009, 183:1528-1532.
23. Dostert C., et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
24. Feldmeyer L., et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr. Biol. 2007, 17:1140-1145.
25. Hornung V., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
26. Kanneganti T.D., et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007, 26:433-443.
27. Cruz C.M., et al. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 2007, 282:2871-2879.
28. Zhou R., et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11:136-140.
29. Rossol M., et al. Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat. Commun. 2012, 3:1329.
30. Lee G.S., et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 2012, 492:123-127.
31. Murakami T., et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11282-11287.
32. Zhong Z., et al. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat. Commun. 2013, 4:1611.
33. Zhou R., et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
34. Ichinohe T., et al. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:17963-17968.
35. Subramanian N., et al. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 2013, 153:348-361.
36. Park S., et al. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J. Immunol. 2013, 191:4358-4366.
37. Ichinohe T., et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206:79-87.
38. Thomas P.G., et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.
39. Allen I.C., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
40. McAuley J.L., et al. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog. 2013, 9:e1003392.
41. Ichinohe T., et al. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 2010, 11:404-410.
42. Ito M., et al. Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog. 2012, 8:e1002857.
43. Triantafilou K., et al. Rhinovirus-induced calcium flux triggers NLRP3 and NLRC5 activation in bronchial cells. Am. J. Respir. Cell Mol. Biol. 2013, 49:923-934.
44. Triantafilou K., et al. Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax 2013, 68:66-75.
45. Burdette D., et al. Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex. J. Gen. Virol. 2012, 93:235-246.
46. Negash A.A., et al. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013, 9:e1003330.
47. Chen W., et al. HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells. PLoS ONE 2014, 9:e84953.
48. Johnson K.E., et al. Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J. Virol. 2013, 87:5005-5018.
49. Rajan J.V., et al. The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J. Virol. 2011, 85:4167-4172.
50. Ramos H.J., et al. IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 2012, 8:e1003039.
51. Kumar M., et al. Inflammasome adaptor protein apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in West Nile virus encephalitis. J. Virol. 2013, 87:3655-3667.
52. Lawrence T.M., et al. Rabies virus is recognized by the NLRP3 inflammasome and activates interleukin-1β release in murine dendritic cells. J. Virol. 2013, 87:5848-5857.
53. Delaloye J., et al. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 2009, 5:e1000480.
54. Kaushik D.K., et al. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS ONE 2012, 7:e32270.
55. Ermler M.E., et al. Rift Valley fever virus infection induces activation of the NLRP3 inflammasome. Virology 2014, 449:174-180.
56. Wu M.F., et al. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood 2013, 121:95-106.
57. Komune N., et al. Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J. Virol. 2011, 85:13019-13026.
58. Faustin B., et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 2007, 25:713-724.
59. Terra J.K., et al. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J. Immunol. 2010, 184:17-20.
60. Masters S.L., et al. NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 2012, 37:1009-1023.
61. Gerlic M., et al. Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:7808-7813.
62. Hornung V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
63. Burckstummer T., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 2009, 10:266-272.
64. Rathinam V.A., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 2010, 11:395-402.
65. Yoneyama M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.
66. Kolakofsky D., et al. A structure-based model of RIG-I activation. RNA 2012, 18:2118-2127.
67. Kawai T., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
68. Arnoult D., et al. Mitochondria in innate immunity. EMBO Rep. 2011, 12:901-910.
69. Kato H., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
70. Fredericksen B.L., Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J. Virol. 2006, 80:2913-2923.
71. Fredericksen B.L., et al. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 2008, 82:609-616.
72. Chang T.H., et al. Flavivirus induces interferon-β gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-κB activation. Microbes Infect. 2006, 8:157-171.
73. Liu P., et al. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 2007, 81:1401-1411.
74. Saito T., et al. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454:523-527.
75. Rintahaka J., et al. Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3. J. Immunol. 2008, 180:1749-1757.
76. Pothlichet J., et al. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog. 2013, 9:e1003256.
77. Poeck H., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production. Nat. Immunol. 2010, 11:63-69.
78. Lu A., et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014, 156:1193-1206.
79. Baroja-Mazo A., et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 2014, 15:738-748.
80. Franklin B.S., et al. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat. Immunol. 2014, 15:727-737.
81. Moore C.B., et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
82. Tattoli I., et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 2008, 9:293-300.
83. Jaworska J., et al. NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E2110-E2119.
84. Unger B.L., et al. Nod-like receptor X-1 is required for rhinovirus-induced barrier dysfunction in airway epithelial cells. J. Virol. 2014, 88:3705-3718.
85. Stasakova J., et al. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1β and 18. J. Gen. Virol. 2005, 86:185-195.
86. Gregory S.M., et al. Discovery of a viral NLR homolog that inhibits the inflammasome. Science 2011, 331:330-334.
87. Dorfleutner A., et al. A Shope fibroma virus PYRIN-only protein modulates the host immune response. Virus Genes 2007, 35:685-694.
88. Johnston J.B., et al. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 2005, 23:587-598.
89. Yoshizumi T., et al. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat. Commun. 2014, 5:4713. 10.1038/ncomms5713.